Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sihuan Pharmaceutical
Beijing, Beijing, China
- Ownership
- Private
- Employees
- ~2667
- Development stage
- Other
01
Overview
Sihuan Pharmaceutical has successfully transitioned from a generic-focused cardiovascular pharmaceutical company to a diversified group with leading positions in medical aesthetics and innovative biopharmaceuticals. In 2024, the company saw significant growth in its medical aesthetics business, driven by the botulinum toxin product Letybo, and achieved commercial launches for innovative drugs like Anaprazole Sodium (XZP-0342) and Janagliflozin (XZP-2687). The company's subsidiaries, Xuanzhu Biopharma and Huisheng Biopharma, have robust pipelines in oncology, metabolism, and digestive diseases with multiple programs at the NDA and Phase 3 stages.
- Therapeutic areas
- EndocrinologyCardiovascularDermatologyGastroenterologyOncology
- Modalities
- Small moleculeBiologicRecombinant proteinMonoclonal antibodyPeptidesAntibody-drug conjugate
- Industry
- Biotech
02
Partnerships
Hugel (Exclusive distribution for Letybo in China)Livzon PharmaceuticalAscendum Capital
Beyond the preview
Go deeper on Sihuan Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sihuan Pharmaceutical.